Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti-Programmed Death 1 Immunotherapy for Recurrent Liver Tumors

LIVER TRANSPLANTATION

卷 27, 期 3, 页码 444-449

WILEY

-

Gastroenterology & Hepatology Surgery Transplantation

1. National Key R&D Program of China [2019YFC1315800, 2019YFC1315802]
2. Shanghai Municipal Key Clinical Specialty
3. National Natural Science Foundation of China [81972232, 81830102, 81772578]
4. Shanghai Municipal Natural Science Foundation [18410720700]